Humana Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Humana Inc trades at $437.41 (market cap $47.61B), while Direxion Daily Semiconductor Bear 3X Shares trades at $31.87 (market cap $1.89B). The key difference: Humana Inc is far larger — about 25.2× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Humana Inc pays a 0.89% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| HUM | SOXS | |
|---|---|---|
Market Cap | $47.61B | $1.89B |
Volume | 1,827,332 | 66,118,733 |
Sector | Health | Leveraged / Inverse |
52-Week High | $409.85 | $988.00 |
52-Week Low | $163.67 | $29.62 |
Typical Hold Time | 53 Days | 11 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $30.645, up 3.43% today, reflecting its inverse leveraged exposure to semiconductor stocks. The technical outlook is bearish, with moving averages signaling strong selling pressure, while oscillators are neutral. Recent news highlights the fund's volatility and tactical use during semiconductor sector weakness, as seen in July 2026 when it surged on chip stock declines. A 1:10 stock split occurred on July 15, 2026, adjusting share structure.
The outlook for SOXS remains highly speculative, suited only for short-term traders betting against semiconductors. Key risks include the fund's decay from daily rebalancing, reliance on sector volatility, and persistent AI demand supporting chip stocks. Investors should avoid long-term holdings due to structural erosion and elevated loss potential in rising markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →